Brand:Hyaluronic acid gel
MOQ:10
Quantity:20
Send Inquiry
1.hyaluronic acid injection grade
2.Hyaluronic Acid fillers for Anti Wrinkle injection
3 good price
hyaluronic acid gel(anti-wrinkle)HA filler,DermalFiller,Wrinkle remover,anti-wrinkle injection
Introduction:
Stabilized Cross-linked hyaluronic acid gel
Used in Plastic surgery operation
Recommended for wrinkles correction and lips enhancement
Model:
1. Fine Lines
HA content:20mg/ml
Particle Size(mm):0.10-0.15
solution for fine lines
2. Derm
HA content:20mg/ml
Particle Size(mm):0.15-0.28
solution for wrinkles
3. Derm deep
HA content:20mg/ml
Particle Size(mm):0.28-0.5
solution for deep wrinkles
4.Sub Skin
HA content:20mg/ml
Particle Size(mm):1.25-2.0
solution for breast and other bodayparts In patients suffering from rheumatoid arthritis(RA) or osteoarthritis (OA) its concentration is halved. HAcontributes to the lubrication of the articulation, shockabsorption and nutrition for the articular tissue. In pathologicalconditions, there is a reduction of the HA synthesis by thesynoviocytes and the production of a form of HA which is not ableto guarantee the metabolic balance with consequent impact on thearticulation. The substitution of the damaged fluid with anintra-articular injection of HA having the same properties of theoriginal synovial fluid is able to restore the physiologicalconditions of the joint.
PRODUCT CHARACTERISTICS:
Is a medical device constituted by a physiological solution ofsodium hyaluronate (NaHA) in sterile syringe for intra-articularinjections ready to use. Hyaluronic Acid is obtained bybio-fermentation (Streptococcus of Lancefields group A and C)
Throughout high purification processes which ensure a final productwith a defined molecular weight (800-1200 KDalton).Is totally freefrom the animal proteins occurring in the extractive materials.Isindicated in case of replacement and/or complementing of synovialfluid damaged following degenerative or traumatic origin diseasesof the articulation.Results in a marked pain reduction, improvementof the articular mobility, decreased use of rescue medication.
The effects Are already evident starting from the 1stinjection (out of a cycle of 3 to 5) and last up to 6 months,suggesting a long-lasting carry-over effect of the treatment.Isavailable in the following ready-to-use formulations:
0.8% (16mg HA in 2mL) for an effective
And well tolerated viscosupplementation in knee OA and otherconditions.
1.6% (32mg HA in 2mL) indicated
Especially for those conditions when a major joint lubrication andan attack therapy in OA are needed.
Mini, a 0.8% physiological solution of sodiumhyaluronate at a low volume (8mg HA in
1mL), in case of infiltration of little joints (e. G.Rhizarthrosis, tenosynovitis, trigger finger).MAIN DIFFERENTIATINGPOINTS FROM OTHER HA
A) Molecular weight
1) Low-to-MID molecular weight (MW) hyaluronic acids which consistin long unbranched chains of natural hyaluronan, not chemicallymodified. Products belonging to this category are ie:
(MW=800-1200 kDa); Hyalgan? (MW=500-730 kDa).Evidences from largeanimal models of OA show that HAs with MW between 500-1000 KDa aremore effective than high MW HAs in reducing synovial inflammationand for the restoration of the rheological properties of synovialfluid (the so-called viscosupplementation effect). 8, 9 2) Highmolecular weight hylans which consist in chemically modifiedcross-linked hyaluronan chains. A product belonging to thiscategory is ie: Synvisc? (MW=6000 kDa).B) Viscoinduction
